Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Kingstone Companies
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Downstate New York And Digital Analytics Will Empower Future Performance
Key Takeaways Strategic partnerships, digital transformation, and data-driven underwriting are expected to expand market share, improve operational efficiency, and enhance profitability. Industry trends favor risk-adjusted premium growth, while portfolio shifts and stronger cash flow are positioned to boost investment returns and net earnings.
View narrative
US$22.00
FV
31.5% undervalued
intrinsic discount
18.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
4 days ago
author updated this narrative
ACR
ACRES Commercial Realty
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Redeployed Capital Will Drive Commercial Real Estate Lending Opportunities
Key Takeaways Redeploying capital into targeted property sectors and new loan originations is expected to drive sustainable revenue and earnings growth. Enhanced operational efficiency, strong credit management, and strategic financing position the company for improved margins and book value.
View narrative
US$22.00
FV
10.5% undervalued
intrinsic discount
-13.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Crexendo
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Cloud Migration And AI Will Shape Future Efficiency
Key Takeaways Enhanced cloud infrastructure, AI innovation, and a growing partner network are driving revenue growth, better margins, and stronger customer retention. Recurring revenue gains and increased contract backlogs are improving revenue predictability and supporting positive long-term profitability prospects.
View narrative
US$8.43
FV
28.7% undervalued
intrinsic discount
10.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
IMPP
Imperial Petroleum
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Fleet Expansion And China's Recovery Will Boost Future Operations
Key Takeaways Expansion of fleet and time charter coverage ensures stable revenue, improved earnings, and operational growth opportunities. Geopolitical factors and rising global oil demand enhance potential for increased profitability and market strength.
View narrative
US$5.50
FV
45.3% undervalued
intrinsic discount
26.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
4 days ago
author updated this narrative
X4 Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
US Launch And EMA Approval Will Expand Global Reach
Key Takeaways The transition to a commercial-stage pharmaceutical and strategic international partnerships could significantly boost revenue growth and international market presence. Successful trials and restructuring efforts anticipate improved profitability and financial sustainability while targeting broader patient populations.
View narrative
US$42.67
FV
96.5% undervalued
intrinsic discount
53.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
4 days ago
author updated this narrative
Lument Finance Trust
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Federal Reserve Rate Cuts Will Secure New Capital Flexibility
Key Takeaways Anticipated rate cuts and stable commercial cap rates may boost revenue through reduced financing costs and increased lending activities. Strategic focus on transitional floating rate mortgages and new financing arrangements enhances liquidity, improving earnings and capital management.
View narrative
US$3.25
FV
28.9% undervalued
intrinsic discount
18.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
Fennec Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expansion Into AYA Segment And International Partnerships Will Drive PEDMARK's Growth In 2025
Key Takeaways Expansion into the adolescent and young adult market for PEDMARK is expected to drive significant revenue growth post-2025 with favorable reimbursement trends. Strategic partnerships in Europe and potential access changes through medical compendia could enhance revenue and earnings growth significantly by mid-2025.
View narrative
US$13.80
FV
39.6% undervalued
intrinsic discount
49.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Lakeland Industries
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Integration And Efficiency Overhauls Will Fortify Future Success
Key Takeaways Strategic acquisitions and expanded geographical market presence are expected to drive revenue growth and improve margins. Efforts in operational efficiencies and organizational enhancements, such as ERP overhaul and a strong management team, aim to boost profitability and shareholder value.
View narrative
US$25.00
FV
43.5% undervalued
intrinsic discount
16.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
SB Financial Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Midwest, Indianapolis And Cincinnati Markets Will Unlock Future Success
Key Takeaways Robust growth in core Midwest and rural markets, along with successful acquisitions and mortgage initiatives, strengthens SB Financial's revenue, market share, and income diversity. Focus on digital transformation and wealth management expansion is enhancing efficiency, customer retention, and fee-based recurring income amid demographic tailwinds.
View narrative
US$23.00
FV
10.0% undervalued
intrinsic discount
-14.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies